Clarisonic
Paris, December 15, 2011 - L’Oréal today announced the completed acquisition of Pacific Bioscience Laboratories, Inc (PBL), the market leader in the rapidly growing areas of sonic skin care devices, topicals and technology. In early November, the two companies had signed a merger agreement paving the way for L’Oréal USA to buy PBL. The move gives L’Oréal access to patented sonic skin care technology enabling the company to acquire strategic positions in the quickly emerging skin care devices category.
“We've spent a fruitful decade developing the Clarisonic family of products for consumers and professionals alike, and the exciting thing is we're just getting started, in a way," said David Giuliani, CEO and co-founder of Pacific Bioscience Laboratories. "L'Oreal's powerful marketing, distribution and R&D resources will help Clarisonic achieve our global mission - empowering people to change the future of their skin.”
Clarisonic® is sold mainly throughout the US and is also present in the UK, Australia, Mexico, Canada and the Far East. It is sold through a distribution network which includes dermatologists and cosmetic surgeons, spas, prestige retail, e-tail, television shopping and clarisonic.com.
In FY 2010, Clarisonic achieved net sales of $ 105 million.
“Clarisonic® is a strategic acquisition for L’Oréal,” said Nicolas Hiéronimus, Managing Director, L’Oréal Luxe Worldwide. “Devices are emerging globally as an important new skin care category. Clarisonic® is the most successful and fast growing premium brand in this category and we will roll it out internationally as well as enhance our service experience in our luxury counters”.
PBL will remain in its new corporate headquarters and manufacturing facility in Redmond, WA, where it has a strong record of invention and technology, and is expected to become another hub of innovation for L’Oréal in the US. “The science behind the Clarisonic brand is unsurpassed in the beauty devices category,” stated Laurent Attal, Executive Vice President, Research & Innovation for L’Oréal S.A. “By combining Pacific Bioscience expertise in devices and L’Oréal skin knowledge and excellence in topical skin care formulations, we think that, together, we will create in Redmond an outstanding center of innovation for L’Oréal.”
PBL’s management team will stay with the company in their respective roles. David Giuliani, who will retain his title as CEO, will report to Carol Hamilton, President L’Oréal Luxe.
©2012 Pacific Bioscience Laboratories Inc. All rights reserved. Privacy Policy